ONESTUDYTEAM
Live / Registered — Registered (as of 10 Oct 2023)
What this means for you
Registered since 10 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97616972
- Registration number
- 7189481
- Mark type
- Stylized text
- Filed
- 03 Oct 2022
- Published for opposition
- 25 Jul 2023
- Registered
- 10 Oct 2023
- Attorney of record
- Rachelle A. Dubow, Esq.
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) featuring software for managing, conducting, and participating in clinical trials and professional computer software consulting services relating to software for managing, conducting, and participating in clinical trials; providing medical and scientific research information, reporting and analysis in the field of clinical trials; Compiling and inputting medical and pharmaceutical clinical trial data for research purposes into a database; providing software as a service (SAAS) services featuring software for reporting, storing, maintaining, and analysing data in the field of medical and pharmaceutical clinical trials
Owner
- Reify Health, Inc., Boston, MA, US
- Reify Health, Inc., Boston, MA, US
- Reify Health, Inc., Boston, MA, US
Prosecution history
- 10 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Apr 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 Apr 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 17 Jan 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jan 2023 — NON-FINAL ACTION E-MAILED
- 17 Jan 2023 — NON-FINAL ACTION WRITTEN
- 17 Jan 2023 — ASSIGNED TO EXAMINER